Science Saturday: Uterine microbe found to have disease-causing behavior in endometrial cancer
A tiny microbe thriving in the uterine microbiome — a population of bacteria, viruses, yeasts/fungi in and around the uterus— could be a contributing driver of endometrial cancer, according to a new Mayo Clinic study.  "We have found that a microbe that is particularly associated with endometrial cancer is capable of pathogenic behavior, and is stimulated by one of the main risk factors for the disease — estrogen exposure," explains Marina Walther-Antonio, Ph.D.,  a researcher within the Mayo… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 4, 2021 Category: Databases & Libraries Source Type: news

NaviFUS to begin FUS terminal brain cancer trial
The Taiwan Food and Drug Administration has approved the use of NaviFUS' focuse...Read more on AuntMinnie.comRelated Reading: MRgFUS shows promise for prostate cancer treatment Philips, InSightec to partner on MRgUS Newer MRgFUS systems work better for uterine fibroids MRgFUS could hurdle Alzheimer's treatment obstacle Focused ultrasound treatment to brain relieves tremors (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 4, 2021 Category: Radiology Source Type: news

Nanotech device can detect risk for serious complication during pregnancy
Researchers from UCLA and Cedars-Sinai have developed a new way to detect a potentially life-threatening condition that can occur during pregnancy.The condition, placenta accreta spectrum disorder, occurs when the placenta grows too deeply into the uterine wall and fails to detach from the uterus after childbirth. It can lead to significant blood loss during pregnancy and delivery, requiring blood transfusions and intensive care, and it can result in serious illness and infection and can even be fatal for the mother. The condition occurs in less than 0.5% of pregnancies.Currently, placenta accreta spectrum disorder is diag...
Source: UCLA Newsroom: Health Sciences - August 3, 2021 Category: Universities & Medical Training Source Type: news

Consumer Health: Endometriosis, ovarian cancer and infertility -- what are the connections?
If you've been diagnosed with endometriosis, you may have questions about whether that raises your risk for other conditions, including ovarian cancer and infertility. With endometriosis, tissue similar to the tissue that normally lines the inside of your uterus grows outside your uterus. Endometriosis most commonly involves your ovaries, fallopian tubes and the tissue lining [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 10, 2021 Category: Databases & Libraries Source Type: news

Reinventing the Uterus, One Organoid at a Time
Bioengineer Linda Griffith once grew a human ear on the back of a mouse. Now she is reframing endometriosis — a “women’s disease” — as a key to unlocking some of biology’s greatest secrets. (Source: NYT Health)
Source: NYT Health - April 27, 2021 Category: Consumer Health News Authors: Rachel E. Gross Tags: your-feed-science your-feed-health Endometriosis Menstruation Reproduction (Biological) Tissue (Human) Pregnancy and Childbirth Gynecology and Gynecologists Breast Cancer Biotechnology and Bioengineering Hysterectomies Source Type: news

Study reveals the 3D structure of human uterine endometrium and adenomyosis tissue
(Niigata University) Recent advances in tissue-clearing-based 3D imaging have permitted researchers to establish a new baseline 3D structure of the endometrial glands, including the formation of a rhizome network in the stratum basalis that expands horizontally along the muscular layer. These findings have implications in understanding the mechanisms underlying normal endometrial tissue processes such as menstruation and fertilized egg implantation, and in clarifying the pathogenesis of endometrium-related diseases, notably adenomyosis, endometriosis, and endometrial cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 13, 2021 Category: International Medicine & Public Health Source Type: news

Brachytherapy may continue following uterine perforation in cervical cancer patients
(Loyola University Health System) A new study finds that brachytherapy, a common procedure that delivers radiation directly to cancer cells, may continue safely, potentially without delay or antibiotics, in cervical cancer patients following uterine perforation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 13, 2021 Category: International Medicine & Public Health Source Type: news

Wireless interventional radiology firm Xenter announces formal launch
Xenter, a company developing wireless technology for use in interventional cardiology...Read more on AuntMinnie.comRelated Reading: FDA clears Philips SmartCT software for image-guided therapy RF ablation relieves pain for bone cancer patients in 3 days Study evaluates safety of new liver cancer treatment E/M coding and billing for interventional radiology Is uterine artery embolization underused for postpartum bleeding? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 8, 2021 Category: Radiology Source Type: news

Researchers identify genes behind uterine leiomyosarcoma
(Yale University) In a new study, Yale Cancer Center researchers have defined the genetic landscape of uterine leiomyosarcomas (uLMS). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 5, 2021 Category: Cancer & Oncology Source Type: news

Endometrial cancer: Patient reduced her thickened endometrial lining naturally
ENDOMETRIAL cancer begins in the uterus - part of the female reproductive system - which the NHS regards as "common", as there are over 9,400 cases each year in the UK. Do you know the warning signs? (Source: Daily Express - Health)
Source: Daily Express - Health - March 21, 2021 Category: Consumer Health News Source Type: news

Is uterine artery embolization underused for postpartum bleeding?
Uterine artery embolization is a better option than hysterectomy for women experiencin...Read more on AuntMinnie.comRelated Reading: Breast MRI effective for postpartum breast cancer SIR: UFE use still lags hysterectomy for fibroids Uterine artery embolization (UAE) in the UAE MRI leads to better therapy for pelvic pain in pregnant, postpartum women (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 17, 2021 Category: Radiology Source Type: news

MRgFUS shows promise for prostate cancer treatment
MRI-guided focused ultrasound (MRgFUS) shows promise as an alternative to surger...Read more on AuntMinnie.comRelated Reading: Newer MRgFUS systems work better for uterine fibroids MRgFUS could hurdle Alzheimer's treatment obstacle Focused ultrasound treatment to brain relieves tremors Ohio tests MRgFUS for epilepsy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 4, 2021 Category: Radiology Source Type: news

Radiological Case: Breast Cancer Metastasis to the Endometrium Radiological Case: Breast Cancer Metastasis to the Endometrium
This patient with a history of Stage IIIB breast cancer presented with abnormal vaginal bleeding. What did imaging reveal regarding the unusual etiology?Applied Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 1, 2021 Category: Consumer Health News Tags: Radiology Journal Article Source Type: news

Research news tip sheet: Story ideas from Johns Hopkins Medicine
(Johns Hopkins Medicine) In a study in mice and human cells, Johns Hopkins Medicine researchers say that they have developed a tiny, yet effective method for preventing premature birth. The vaginally delivered treatment contains nanosized (billionth of a meter) particles of drugs that easily penetrate the vaginal wall to reach the uterine muscles and prevent them from contracting. If proven effective in humans, the treatment could be one of the only clinical options available to prevent preterm labor. The FDA has recommended removing Makena (17-hydroxyprogesterone caproate), the only approved medicine for this purpose, fro...
Source: EurekAlert! - Cancer - January 19, 2021 Category: Cancer & Oncology Source Type: news

Radiotherapy for Rectal Cancer Linked to Risk for Later Malignant Gynecological Neoplasms Radiotherapy for Rectal Cancer Linked to Risk for Later Malignant Gynecological Neoplasms
Women who receive radiotherapy for rectal cancer may be at an increased risk of uterine and ovarian cancer, a new study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 11, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Science Saturday: Conquering cancer by targeting its genetic abnormalities
Joanne Garnett has harrowing memories of that life-changing day back in 1981. She was a 39-year-old land use planner living in Wyoming when she received a call from her doctor confirming she had uterine cancer.  "I was shocked, and it was strange because I didn't fit any profile for uterine cancer," Garnett recalls. "I got a [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - January 9, 2021 Category: Research Source Type: news

Broadening participation in clinical trials: A win for all
The objective is to engage in rea l-world, evidence-based research and bring trials to the local community, where a significant proportion of cancer care is rendered,” he adds.   To help, Cardinal Health ’s real-world evidence and insights teams analyze the real-world data collected from the sites, which can be compared to results from clinical trials to demonstrate the real-world value of therapies.   By bringing these studies to the community, many of the usual challenges are overcome, adds Gajra. These include trial site location (typically academic institutions) and the distances that ...
Source: EyeForPharma - January 6, 2021 Category: Pharmaceuticals Authors: Joseph Constance Source Type: news

Mesothelioma Surgery with Organ Removal Extends Survival
Removing major organs to achieve a more complete cancer resection did not increase severe complications or hinder survival benefits of aggressive surgery for patients with peritoneal mesothelioma, according to a recent report. The increased complexity of organ resection surgery will not adversely affect long-term outcomes, according to the multicenter study published in Annals of Surgical Oncology. By comparison, an incomplete cytoreduction that can spare the organs is associated with increased mortality and shorter overall survival. The study, which involved 174 patients across 12 specialty centers within the U.S., accent...
Source: Asbestos and Mesothelioma News - November 17, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

Women's Wellness: Uterine fibroids are common noncancerous growths
Uterine fibroids are noncancerous growths of the uterus that often appear during childbearing years. Also called leiomyomas (lie-o-my-O-muhs) or myomas, uterine fibroids aren't associated with an increased risk of uterine cancer and almost never develop into cancer. Fibroids range in size from seedlings, undetectable by the human eye, to bulky masses that can distort and [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - October 16, 2020 Category: Research Source Type: news

Is Uterus Cancer Fatal?
Title: Is Uterus Cancer Fatal?Category: Diseases and ConditionsCreated: 9/30/2020 12:00:00 AMLast Editorial Review: 9/30/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - September 30, 2020 Category: Cancer & Oncology Source Type: news

Women's Wellness: Obesity increases endometrial cancer risk
Endometrial cancer, which begins in the uterus within the layer of cells that form the uterine lining, has been on the rise over the past decade. Each year in the U.S., over 60,000 women are diagnosed with endometrial cancer, also referred to as uterine cancer. Endometrial cancer is now the most common cancer to affect [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 16, 2020 Category: Databases & Libraries Source Type: news

First US clinical trial testing efficacy of delivering aerosolized chemotherapy
(City of Hope) City of Hope surgical researchers are the first in the nation to open a clinical trial that could one day become an effective way to deliver chemotherapy to abdominal cancer patients who currently have very few treatment options. Ovarian, uterine, gastric and colorectal cancers can be difficult to treat using traditional intravenous chemotherapy, especially when the tumors spread to a thin layer of tissue that lines the abdomen called the peritoneum. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 11, 2020 Category: Cancer & Oncology Source Type: news

Most women treated in New York City for gynecologic cancers
(NYU Langone Health / NYU School of Medicine) Women receiving standard treatment in New York City for ovarian, uterine, and cervical cancers are not at increased risk of being hospitalized for or dying from COVID-19 due to their cancer, a new study shows. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 30, 2020 Category: International Medicine & Public Health Source Type: news

Why this Peninsula drug maker's stock soared 40% higher today
Shares of Myovant Sciences Ltd. soared as much as 55% Monday after the company this weekend unloaded fresh data around a drug for prostate cancer and said this morning that it is asking regulators to approve the same drug's use to treat women with uterine fibroids. The 214-employee company (NYSE: MYOV), with its main offices in Brisbane, said a late-stage prostate cancer study of its drug relugolix expanded on earlier findings, finding its once-a-day pill has a lower risk of heart problems compared… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 1, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Why this Peninsula drug maker's stock soared 40% higher today
Shares of Myovant Sciences Ltd. soared as much as 55% Monday after the company this weekend unloaded fresh data around a drug for prostate cancer and said this morning that it is asking regulators to approve the same drug's use to treat women with uterine fibroids. The 214-employee company (NYSE: MYOV), with its main offices in Brisbane, said a late-stage prostate cancer study of its drug relugolix expanded on earlier findings, finding its once-a-day pill has a lower risk of heart problems compared… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 1, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news

Adavosertib Induces Tumor Shrinkage in 30% of Patients with Uterine Serous Carcinoma
A recent clinical trial ’s results found that a targeted drug known as adavosertib caused tumors in nearly 30% of patients examined with uterine serous carcinoma, a hard-to-treat form of uterine cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 29, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news

New targeted agent produces considerable responses in patients with uterine cancer
(Dana-Farber Cancer Institute) The DNA repair-blocking drug adavosertib shrinks tumors in nearly one-third of patients in clinical trial data to be shared at the Society for Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 23, 2020 Category: Cancer & Oncology Source Type: news

Gene signature found for poor response to standard chemotherapy in rare uterine cancer
(Medical College of Georgia at Augusta University) Women who don't survive a rare and aggressive uterine cancer called uterine serous carcinoma, have high expression of a group of 73 genes, a score scientists say can help identify these women and improve their outcome. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

Human uterus colonized by clones with cancer-driving mutations that arise early in life
(Wellcome Trust Sanger Institute) Many cells in the inner lining of the uterus carry 'cancer-driving' mutations that frequently arise early in life, report scientists from the Wellcome Sanger Institute, the University of Cambridge and their collaborators. The research team conducted whole-genome sequencing of healthy human endometrium, providing a comprehensive overview of the rates and patterns of DNA changes in this tissue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 22, 2020 Category: Cancer & Oncology Source Type: news

New, detailed molecular roadmap boosts fight against endometrial cancer
(DOE/Pacific Northwest National Laboratory) Scientists have taken an unprecedented look at the proteins involved in endometrial cancer, commonly known as uterine cancer. The study offers insights about how physicians might be able to better identify which patients will need aggressive treatment and which won't, and offers clues about why a common cancer treatment is not effective with some patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 13, 2020 Category: Cancer & Oncology Source Type: news

What Do You Do For Breast Milk Jaundice?
Discussion Almost all infants in the first few days of life have some elevation of their bilirubin because of the various physiologic changes they undergo in the transition to extra-uterine life. This is a common problem managed by many different inpatient and outpatient healthcare providers. This hyperbilirubinemia is usually unconjugated and resolves in the first 1-2 weeks of life. However, when it does not resolve, health care providers have 3 general paths to follow when considering a cause: inadequate breast milk intake, an underlying organic cause or breast milk jaundice. Inadequate breastfeeding is not uncommon and...
Source: PediatricEducation.org - February 3, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

With prostate cancer trial done, Peninsula drug maker will ask for FDA approval
Myovant Sciences also will seek FDA approval next year of a different version of the same drug to treat heavy menstrual bleeding in women with uterine fibroids. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 3, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news

With prostate cancer trial done, Peninsula drug maker will ask for FDA approval
Myovant Sciences also will seek FDA approval next year of a different version of the same drug to treat heavy menstrual bleeding in women with uterine fibroids. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 3, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

The Prognosis of Stage IA Mixed Endometrial Carcinoma The Prognosis of Stage IA Mixed Endometrial Carcinoma
A study determines that the serous subtype may be associated with a poor prognosisin in uterine cancer.American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 31, 2019 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

AI can accurately predict uterine fibroid embolization outcomes
An artificial intelligence (AI) algorithm's analysis of MRI exams performed...Read more on AuntMinnie.comRelated Reading: SIR: UFE bests myomectomy for fibroid treatment Artificial intelligence for MRI distinguishes uterine cancer from fibroids Study finds low reintervention rate for UAE of fibroids Further intervention rates vary after fibroid removal Online patient info about UAE could be better (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 13, 2019 Category: Radiology Source Type: news

Linkage between evolution of pregnancy and cancer spread explained
In humans, the placenta invades the wall of the uterus in much the same way that cancer cells invade the surrounding tissues at the outset of metastasis. (Source: Yale Science and Health News)
Source: Yale Science and Health News - November 26, 2019 Category: Universities & Medical Training Source Type: news

CVD mortality much higher among cancer patients
CVD mortality highest in first year from diagnosis; and also much higher for bladder, larynx, prostate and uterine cancers Related items fromOnMedica Exercise essential for people diagnosed with cancer NHS must improve access to screening to save lives Metastatic breast cancer goes undiagnosed for too long Cancer strategies failed to improve one-year survival Cancer mortality cut by a third in young people (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 25, 2019 Category: UK Health Source Type: news

UCLA Mattel Children ’s Hospital helps kids trick-or-treat
Three-year-old Harmon Jones strutted in his “Black Panther” costume as he prowled the UCLA Mattel Children’s Hospital hallways and main lobby for treats. After watching a special magic show and playing some tunes led by music therapists, he wanted some Halloween candy.“My favorite part is the lollipops!” Harmon said. “I like to share them with my mommy and daddy!”For Heather and Shaw Jones, Harmon ’s parents, holidays bring some sense of the normal and community. Last summer, Harmon was diagnosed with rhabdomyosarcoma, a rare cancer that forms in soft tissue — specifica...
Source: UCLA Newsroom: Health Sciences - November 1, 2019 Category: Universities & Medical Training Source Type: news

Study: Women Who Use IUDs May Have Lower Risk Of Ovarian Cancer
BOSTON (CBS) – Not only do IUDs prevent pregnancy, they may lower the risk of ovarian cancer in the women who use them. Researchers at the University of Colorado reviewed a dozen prior studies involving several thousand patients and found that women who used IUDs were up to 32-percent less likely than other women to develop ovarian cancer. It’s not clear why, but scientists found that the hormones released by some IUDs may block estrogen which help ovarian tumor glow. And having a foreign body in the uterus may trigger the immune system to help fight cancer. Birth control pills have also been linked to a lower ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 17, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Healthwatch News Syndicated CBSN Boston Syndicated Local Dr. Mallika Marshall IUD ovarian cancer Source Type: news

Hysterectomy Technique Tied to Poorer Uterine Cancer Outcomes
Uncontained uterine power morcellation tied to higher mortality in women with undetected uterine cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 7, 2019 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Surgery, Journal, Source Type: news

Hysterectomy Technique Tied to Poorer Uterine Cancer Outcomes
MONDAY, Oct. 7, 2019 -- Uncontained power morcellation is associated with a higher mortality risk in women with occult uterine sarcoma, especially in those with occult leiomyosarcoma, according to a study published online Sept. 16 in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 7, 2019 Category: Pharmaceuticals Source Type: news

Unexpected Uterine Cancer: Power Morcellation and Mortality
A study recently published in the Journal of Clinical Oncology reported on the association between power morcellation and mortality in women with unexpected uterine cancer who were undergoing a hysterectomy or myomectomy. (Source: CancerNetwork)
Source: CancerNetwork - October 1, 2019 Category: Cancer & Oncology Authors: Leanne Marcello, MS Source Type: news

Hysterectomy Procedure Tied to Worse Cancer Outcomes
THURSDAY, Sept. 19, 2019 -- Women who must have their uterus removed should be wary of a procedure called uncontained uterine power morcellation, Yale University researchers warn. This once common surgical option for hysterectomy or myomectomy... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 19, 2019 Category: General Medicine Source Type: news

Once-common hysterectomy technique linked to worse uterine cancer outcomes
Uncontained uterine power morcellation, a laparoscopic hysterectomy technique, may worsen outcomes for women who have undiagnosed uterine cancer. (Source: Yale Science and Health News)
Source: Yale Science and Health News - September 16, 2019 Category: Universities & Medical Training Source Type: news

Women Who Use IUDs May Be At Lower Risk For Ovarian Cancer, Study Finds
BOSTON (CBS) – Nearly 14,000 American women will die from ovarian cancer this year, but a new study from the UCHealth University of Colorado Hospital finds that women who use IUDs may be at lower risk. The symptoms of ovarian cancer can be mild or vague and there is no reliable screening test, so the diagnosis often isn’t made until it’s pretty advanced. But a new study of thousands of women around the world found that women who use intrauterine devices, or IUDs, for contraception may be 15-32% less likely to develop ovarian cancer. It’s not clear for how long they need to use one or why they may be...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 11, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston Syndicated Local Dr. Mallika Marshall HealthWatch IUD Source Type: news

Mayo Clinic Minute: 3 things women should know about gynecologic cancer
Cancer of a woman's reproductive organs is referred to as "gynecologic cancer." Dr. Amanika Kumar, a Mayo Clinic OB-GYN, says there are many forms of gynecologic cancer: endometrial or uterine, ovarian, vulvar, cervical, and vaginal. Watch: The Mayo Clinic Minute https://youtu.be/G6371uKfois Journalists: Broadcast-quality video pkg (0:58) is in the downloads at the end of the post. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 8, 2019 Category: Databases & Libraries Source Type: news

Two Genes Conspire in Endometriosis and Cancer to Help Cells Migrate
The genes promote the migration of endothelial cells outside of the uterus, a characteristic of both endometriosis and endometrial cancers, a study of mice and human tissue finds. (Source: The Scientist)
Source: The Scientist - August 9, 2019 Category: Science Tags: News & Opinion Source Type: news

Podcast: Use of computer or robotic technology to assist surgeons in performing gynaecological surgery
In conclusion, low-certainty evidence for hysterectomy and sacrocolpopexy operations suggests that complication rates for robot-assisted surgery might be similar to those for conventional laparoscopic surgery. Things are more uncertain for gynaecological cancer, where we found no comparative evidence on cancer recurrence or survival after the surgery. As robot-assisted surgery depends on the skill and experience of the surgeon and is expensive, evaluating its effectiveness and safety continues to present a challenge; but this needs to be met if we are to have reliable evidence on its potential benefits and harms.Read the C...
Source: Cochrane News and Events - August 9, 2019 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Molecular analysis could improve the early detection and prevention of endometrial cancer
(IDIBELL-Bellvitge Biomedical Research Institute) Researchers from IDIBELL and ICO lead the proposal to evaluate genomic analyzes in cervical cytologies to improve the detection of cancer of the uterine cavity. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 17, 2019 Category: Cancer & Oncology Source Type: news

Radiation plus chemotherapy doesn't improve endometrial cancer recurrence-free survival
(Northwestern University) The standard of care for women with stage III/IVA endometrial cancer following surgery has been chemotherapy and radiation to prevent recurrence. But in a surprising new finding, radiation combined with chemotherapy did not increase recurrence-free survival in these women, reports a National Cancer Institute-sponsored study. Chemotherapy alone should now be the standard of care for stage III uterine cancer, the lead author said. This is the first study comparing the combined regimen to chemotherapy alone. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 12, 2019 Category: Cancer & Oncology Source Type: news